| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/21/2013 | CA2601209C Bovine cast gene snp and meat tenderness |
| 05/21/2013 | CA2569988C Phage microarray profiling of the humoral response to disease |
| 05/21/2013 | CA2560782C Methods and compositions for the detection of cervical disease |
| 05/21/2013 | CA2558946C Novel method for the preparation of embryoid bodies (ebs) and uses thereof |
| 05/21/2013 | CA2519285C Papanicolau staining process |
| 05/21/2013 | CA2518541C Gonadal function improving agents |
| 05/21/2013 | CA2496321C Biomarkers for diagnosing alzheimer's disease |
| 05/21/2013 | CA2460092C A method of diagnosis and treatment and agents useful for same |
| 05/21/2013 | CA2412436C Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 05/21/2013 | CA2370405C Nucleic acid molecules from wheat, transgenic plant cells and plants and the use thereof for the production of modified starch |
| 05/21/2013 | CA2363662C Sequences and methods for detection of hiv-1 |
| 05/21/2013 | CA2279329C Protein fragment complementation assays to detect biomolecular interactions |
| 05/18/2013 | CA2796520A1 Method for identifying cancer drug candidates in drosophila |
| 05/16/2013 | WO2013071247A1 Gene expression signatures of neoplasm responsiveness to theraphy |
| 05/16/2013 | WO2013071239A1 Cerebrospinal fluid assay |
| 05/16/2013 | WO2013071237A1 Mutant protease biosensors with enhanced detection characteristics |
| 05/16/2013 | WO2013071233A1 Methods for detecting infectious agents and a novel virus detected thereby |
| 05/16/2013 | WO2013071231A1 Channelrhodopsins for optical control of cells |
| 05/16/2013 | WO2013071224A1 Method for detecting a target analyte using a self-cleaving synthetic molecule |
| 05/16/2013 | WO2013071168A1 Polypeptide substrate for the detection of von willebrand factor cleaving protease adamts13 |
| 05/16/2013 | WO2013071163A2 Biomarkers of response to proteasome inhibitors |
| 05/16/2013 | WO2013071159A1 Bacterial metastructure and methods of use |
| 05/16/2013 | WO2013071142A1 Biomarkers of response to proteasome inhibitors |
| 05/16/2013 | WO2013071119A2 Methods for treating, diagnosing and monitoring alzheimer's disease |
| 05/16/2013 | WO2013071066A1 Signatures associated with the response to cancer therapy |
| 05/16/2013 | WO2013070990A1 Co-binder assisted assay methods |
| 05/16/2013 | WO2013070984A1 Systems and integrated methods for gene expression analysis in multiple sclerosis |
| 05/16/2013 | WO2013070962A1 Methods and uses for metabolic profiling for clostridium difficile infection |
| 05/16/2013 | WO2013070953A1 Lysosomal enzyme assay methods and compositions |
| 05/16/2013 | WO2013070950A1 Identification of a dna methylation marker for blood-based detection of ovarian cancer |
| 05/16/2013 | WO2013070894A1 Method of identifying prebiotics and compositions containing the same |
| 05/16/2013 | WO2013070893A1 Method of making cosmetic compositions containing a prebiotic |
| 05/16/2013 | WO2013070891A1 Method of identifying prebiotics and compositions containing the same |
| 05/16/2013 | WO2013070849A1 Screening methods for ocular irritation and toxicity |
| 05/16/2013 | WO2013070807A1 Niche targeting of quiescent cancer stem cells |
| 05/16/2013 | WO2013070765A1 Assay for the prediction of therapeutic effectiveness or potency of mesenchymal stem cells, and methods of using same |
| 05/16/2013 | WO2013070763A1 Aptamer-loaded, biocompatible nanoconstructs for nuclear-targeted cancer therapy |
| 05/16/2013 | WO2013070662A1 Sequences and their use for detection of salmonella |
| 05/16/2013 | WO2013070521A1 Method of predicting breast cancer prognosis |
| 05/16/2013 | WO2013070230A1 Method and medium for detecting an antibiotic resistant pathogenic staphylococci in a test sample |
| 05/16/2013 | WO2013070115A1 Method for identifying species and strains of bifidobacteria using genes of the type ii toxin-antitoxin systems of the mazef and reibe superfamilies |
| 05/16/2013 | WO2013070089A1 Method and materials for the diagnosis of prostate cancers |
| 05/16/2013 | WO2013070088A1 Methods and materials for determining the efficacy of prostate cancer therapies |
| 05/16/2013 | WO2013070079A2 miRNA IN BLOOD BRAIN BARRIER OF MS PATIENTS |
| 05/16/2013 | WO2013070060A1 One step multiplex system for the detection of salmonella spp., s. typhi and s. paratyphi a with an internal control |
| 05/16/2013 | WO2013069773A1 Base-supporting labeling method, base sequence information acquisition method, and base-supporting labeled single-stranded nucleic acid |
| 05/16/2013 | WO2013069732A1 Magnetic nanoparticles |
| 05/16/2013 | WO2013069645A1 Method for measuring ethanolamine phosphate |
| 05/16/2013 | WO2013069495A1 Method for predicting risk of porencephaly or cerebral hemorrhage |
| 05/16/2013 | WO2013069452A1 Method for observing stem cells, method for removal of cell region in state tending toward differentiation, and device for observing stem cells |
| 05/16/2013 | WO2013068730A1 Micro -rnas as marker for platelet activity |
| 05/16/2013 | WO2013068685A1 Method for detecting delta haemolysin of staphylococcus aureus by mass spectrometry directly using a bacterial population |
| 05/16/2013 | WO2013068654A1 Method and primers for the detection of microcystin-producing toxic cyanobacteria |
| 05/16/2013 | WO2013068572A2 Blood sample assay method |
| 05/16/2013 | WO2013068528A1 Methods for determining nucleotide sequence repeats |
| 05/16/2013 | WO2013068486A1 Methods for the diagnosis and treatment of male infertility |
| 05/16/2013 | WO2013068445A1 Diacylglycerol lipase and uses thereof |
| 05/16/2013 | WO2013068422A1 Method for normalization of quantitative pcr and microarrays |
| 05/16/2013 | WO2013068347A1 Prognostic method for checking efficacy of micro rna-122 inhibitors in hcv+ patients |
| 05/16/2013 | WO2013068107A1 Lysis method and lysis composition |
| 05/16/2013 | WO2013068103A1 Novel complex mutations in the epidermal growth factor receptor kinase domain |
| 05/16/2013 | WO2013042993A9 Sprex-dna chip kit for detecting high-resolution mica alleles |
| 05/16/2013 | WO2013042964A3 Novel bacteriophage and antibacterial composition comprising the same |
| 05/16/2013 | WO2013040099A3 Sepsis prognosis biomarkers |
| 05/16/2013 | WO2013040060A3 Nucleic acids for multiplex detection of hepatitis c virus |
| 05/16/2013 | WO2013009084A3 Composition for simultaneously detecting mycobacterium tuberculosis and nontuberculous mycobacteria by means of real-time multiplex polymerase chain reaction comprising nested hybridization pna probe system having parallel binding structure, and method for detection using same |
| 05/16/2013 | WO2013009070A9 Nested hybridization pna probe system having parallel binding structure |
| 05/16/2013 | WO2013007944A9 Material for supported synthesis and method for growing oligonucleotides or peptides |
| 05/16/2013 | WO2013001369A3 Therapeutic and diagnostic target |
| 05/16/2013 | WO2012173994A3 Phase changing formulations of nucleic acid payloads |
| 05/16/2013 | WO2012167163A3 Methods and compositions for detecting endometrial or ovarian cancer |
| 05/16/2013 | WO2012159025A3 Chromosome conformation analysis |
| 05/16/2013 | WO2012135696A3 Methods and compositions for the diagnosis, classification, and treatment of cancer |
| 05/16/2013 | WO2012126542A3 Biomarkers and methods for the prognosis of glioblastoma |
| 05/16/2013 | US20130125259 Rna interference mediating small rna molecules |
| 05/16/2013 | US20130125253 Insect resistant cotton plants and methods for identifying same |
| 05/16/2013 | US20130124099 Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby |
| 05/16/2013 | US20130123594 Electrochemical Sensor |
| 05/16/2013 | US20130123484 Position dependent recognition of gnn nucleotide triplets by zinc fingers |
| 05/16/2013 | US20130123475 Non-Fluorescent Quencher Compounds and Biomolecular Assays |
| 05/16/2013 | US20130123360 Methods and uses relating to the identification of compound associated with bacterial infection |
| 05/16/2013 | US20130123341 Methods, compositions and kits for diagnosing and treating Alzheimer's disease using mitochondrial CO3 gene mutations |
| 05/16/2013 | US20130123335 Idh1 and idh2 mutations in cholangiocarcinoma |
| 05/16/2013 | US20130123328 Methods and compositions for treating cancer |
| 05/16/2013 | US20130123189 Determination of single nucleotide polymorphisms useful to predict response for glatiramer acetate |
| 05/16/2013 | US20130123188 METHODS FOR DIAGNOSING AND TREATING ALZHEIMER'S DISEASE (AD) USING THE MOLECULES THAT STABILIZE INTRACELLULAR CALCIUM (Ca2+) |
| 05/16/2013 | US20130123187 Peptides for the regulation of neurotransmitter sequestration and release |
| 05/16/2013 | US20130123170 Growth Hormone Releasing Peptides |
| 05/16/2013 | US20130123146 Method of making a microbead array with attached biomolecules |
| 05/16/2013 | US20130123143 Method for identifying a compound having an antiarrhythmic effect as well as uses relating thereto |
| 05/16/2013 | US20130123140 Identification of compounds modifying a cellular response |
| 05/16/2013 | US20130123138 Compositions and methods for prognosis of mesothelioma |
| 05/16/2013 | US20130123136 Real-time electronic cell sensing system and applications for cytotoxicity profiling and compound assays |
| 05/16/2013 | US20130123135 Methods To Identify Modulators of TAS2R48 Receptors |
| 05/16/2013 | US20130123133 Screening methods |
| 05/16/2013 | US20130123131 Process for Ensuring Consistency and Reproducibility of a Diagnostic or Research Method |
| 05/16/2013 | US20130123130 Multigene prognostic assay for lung cancer |
| 05/16/2013 | US20130123129 Use of dnazymes for analysis of an rna sample |
| 05/16/2013 | US20130123128 Method for the detection of schizophrenia related gene transcripts in blood |
| 05/16/2013 | US20130123127 Microarrays and uses thereof |